The effect of plasma drug concentrations on HIV-1 clearance rate during quadruple drug therapy.
Hoetelmans RM, Reijers MH, Weverling GJ, ten Kate RW, Wit FW, Mulder JW, Weigel HM, Frissen PH, Roos M, Jurriaans S, Schuitemaker H, de Wolf F, Beijnen JH, Lange JM.
Hoetelmans RM, et al. Among authors: jurriaans s.
AIDS. 1998 Jul 30;12(11):F111-5. doi: 10.1097/00002030-199811000-00002.
AIDS. 1998.
PMID: 9708400
Clinical Trial.